Chemokine Profiles Are Affected in Serum of Patients with Acute Rejection of Kidney Allograft
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2021 (1)
Abstract
Kidney allograft transplantation improved the prognosis and quality of life of patients with end‐stage renal diseases but the occurrence of acute rejection represents a limitation of the final outcome. Noninvasive biomarkers are needed as well as further advancements in the understanding of immune mechanisms of reaction to the allograft. Our study of 138 patients focused on one‐year monitoring of serum concentrations of 12 chemokines regulating the recruitment of different immune cells into transplanted allograft and on in vitro regulation of the same chemokines release by interactions of renal proximal epithelial cells with monocyte/macrophage cell line stimulated with TNF alpha. In a group of 44 patients with acute rejection, higher serum pretransplant levels of CXCL1, CXCL5, CXCL6, CCL2, CCL21, and particularly CXCL10 and CX3CL1(both p < 0.001) were found suggesting their higher proinflammatory status as compared to subjects with the uncomplicated outcome. In samples collected at the day of biopsy positive for acute rejection, chemokines CXCL9 and CXCL11 attracting preferentially Th1 lymphocytes were found to be upregulated. In our in vitro model with TNF alpha induction, renal proximal epithelial cells seemed to be a more potent source of chemokines attracting neutrophils as compared to monocyte/macrophage cell line but the coculture of these cells potentiated release of neutrophilic chemokines CXCL5 and CXCL6. Similar augmentation of chemokine production was found also in the case of CCL2. On the other hand, adding of monocytes/macrophages to a culture of renal epithelial cells suppressed the release of CXCL10 and CXCL11 attracting T lymphocytes. We assume from our data that in kidney allograft transplantation, chemokines attracting neutrophils, T lymphocytes, and monocytes are induced simultaneously and measurement some of them in combination might be used as biomarkers of acute rejection. Mutual cell‐cell interactions of immune cells with renal parenchyma seem to be important for fine regulation of chemokine release.Keywords
Funding Information
- Ministerstvo Zdravotnictví Ceské Republiky (00023001, 15-26883A)
This publication has 39 references indexed in Scilit:
- Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsiesAmerican Journal of Transplantation, 2019
- Chemokine Receptor Redundancy and Specificity Are Context DependentImmunity, 2019
- Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and StrategiesFrontiers in Medicine, 2019
- The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trialsAmerican Journal of Transplantation, 2017
- International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine ReceptorsPharmacological Reviews, 2014
- Control of Neutrophil Inflammation at Mucosal Surfaces by Secreted Epithelial ProductsFrontiers in Immunology, 2013
- Systematic classification of vertebrate chemokines based on conserved synteny and evolutionary historyGenes to Cells, 2012
- Neutrophil‐active chemokines in in vivo imaging of neutrophil traffickingEuropean Journal of Immunology, 2012
- Touch of ChemokinesFrontiers in Immunology, 2012
- Chemokines: Roles in leukocyte development, trafficking, and effector functionJournal of Allergy and Clinical Immunology, 2003